Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17))
Publication
, Journal Article
Holman, RR; Sourij, H; Califf, RM
Published in: Lancet
January 1, 2014
Duke Scholars
Published In
Lancet
DOI
EISSN
1474-547X
ISSN
0140-6736
Publication Date
January 1, 2014
Volume
383
Issue
9936
Start / End Page
2212
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holman, R. R., Sourij, H., & Califf, R. M. (2014). Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)). Lancet, 383(9936), 2212. https://doi.org/10.1016/S0140-6736(14)61084-9
Holman, R. R., H. Sourij, and R. M. Califf. “Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)).” Lancet 383, no. 9936 (January 1, 2014): 2212. https://doi.org/10.1016/S0140-6736(14)61084-9.
Holman RR, Sourij H, Califf RM. Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)). Lancet. 2014 Jan 1;383(9936):2212.
Holman, R. R., et al. “Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)).” Lancet, vol. 383, no. 9936, Jan. 2014, p. 2212. Scopus, doi:10.1016/S0140-6736(14)61084-9.
Holman RR, Sourij H, Califf RM. Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)). Lancet. 2014 Jan 1;383(9936):2212.
Published In
Lancet
DOI
EISSN
1474-547X
ISSN
0140-6736
Publication Date
January 1, 2014
Volume
383
Issue
9936
Start / End Page
2212
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences